Company Executives

Management Team

From the proxy statement filed Apr 21, 2026

Officer	Age	In this role	Joined	2025 pay	Source
John Duke Also a director President and Chief Executive Officer	55	Not stated	Not stated	$905,208
Mark Frost Chief Financial Officer and Treasurer	63	Not stated	2025	$343,518

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 21, 2026

Directors

serving now

Independent

5 of 6

stated in the proxy

Average tenure

2.3 years

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	Pay
John Duke CEO	55	2025 1 year	Not independent	None stated	None stated	Paid as CEO
Katherine A. Eade Lead independent director	52	2017 9 years	Independent	Nominating and Governance Committee · Chair Audit Committee	None stated	Not stated
Stephen DeNelsky	58	2025 1 year	Independent	Compensation Committee · Chair Nominating and Governance Committee	None stated	Not stated
Robert Gagnon	52	2025 1 year	Independent	Audit Committee · Chair Compensation Committee	Verastem Oncology, Bone Biologics Corporation, Purple Biotech Ltd	Not stated
Seth Benson	46	2025 1 year	Independent	Audit Committee	None stated	Not stated
William Snider	56	2025 1 year	Independent	Compensation Committee	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 21, 2026

BroadOak Income Fund and BroadOak Fund VI

William Snider is a partner of BroadOak Capital Partners, and manager of BroadOak Income Fund and BroadOak Fund VI, and joined our Board of Directors in connection with the entry into the Loan Agreement

Amount not stated

December 17, 2025

Company, as borrower, entered into a Loan and Security Agreement providing term loans of $10.0 million (Term A), $22.5 million (Term B) and $7.5 million (Term C, convertible into Common Stock at $10.00 per share), with interest at the greater of 12.80%/12.50% or prime plus 5.25%, and a 10.00% exit fee

With Lenders party to the Loan and Security Agreement, with BroadOak Income Fund as administrative and collateral agent Open in proxy

Comments

Company Executives

Management Team

Board of Directors

Related-party transactions